SCRIPPS RESEARCH INSTITUTE, THE
Engineering durable immunity by optimizing HIV vaccine parameters to drive long-lived plasma cell development
Engineering durable immunity by optimizing HIV vaccine parameters to drive long-lived plasma cell development is a funding opportunity from SCRIPPS RESEARCH INSTITUTE, THE, up to 1379954, closing July 31, 2030.
Jul 31, 2030
(1461d left)Overview
PROJECT SUMMARY The HIV pandemic has been raging for nearly forty years, and despite immense effort we have yet to discover a vaccine that can induce durable, protective immunity. HIV remains an urgent global health crisis, with 38 million people living with HIV and 1.5 million people newly infected each year. For…